Menu
GeneBe

15-76203962-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000388942.9(TMEM266):c.1219C>T(p.Arg407Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,459,696 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000013 ( 1 hom. )

Consequence

TMEM266
ENST00000388942.9 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.21
Variant links:
Genes affected
TMEM266 (HGNC:26763): (transmembrane protein 266) Enables protein homodimerization activity. Predicted to be involved in transmembrane transport. Located in cytosol; dendrite; and plasma membrane. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
ETFA (HGNC:3481): (electron transfer flavoprotein subunit alpha) ETFA participates in catalyzing the initial step of the mitochondrial fatty acid beta-oxidation. It shuttles electrons between primary flavoprotein dehydrogenases and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. Defects in electron-transfer-flavoprotein have been implicated in type II glutaricaciduria in which multiple acyl-CoA dehydrogenase deficiencies result in large excretion of glutaric, lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12299079).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TMEM266NM_152335.5 linkuse as main transcriptc.1219C>T p.Arg407Cys missense_variant 11/11 ENST00000388942.9
TMEM266XM_047432151.1 linkuse as main transcriptc.1243C>T p.Arg415Cys missense_variant 13/13
TMEM266XM_017021915.2 linkuse as main transcriptc.1243C>T p.Arg415Cys missense_variant 13/13
TMEM266XM_005254160.4 linkuse as main transcriptc.691C>T p.Arg231Cys missense_variant 9/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TMEM266ENST00000388942.9 linkuse as main transcriptc.1219C>T p.Arg407Cys missense_variant 11/115 NM_152335.5 P1Q2M3C6-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000202
AC:
5
AN:
247888
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
134176
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.0000871
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000130
AC:
19
AN:
1459696
Hom.:
1
Cov.:
36
AF XY:
0.0000138
AC XY:
10
AN XY:
725850
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.0000672
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.0000113
ExAC
AF:
0.00000824
AC:
1
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 15, 2023The c.1243C>T (p.R415C) alteration is located in exon 11 (coding exon 10) of the TMEM266 gene. This alteration results from a C to T substitution at nucleotide position 1243, causing the arginine (R) at amino acid position 415 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.51
Cadd
Benign
20
Dann
Benign
0.97
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D
PROVEAN
Benign
-0.84
N
REVEL
Benign
0.047
Sift
Benign
0.14
T
Sift4G
Benign
0.092
T
Polyphen
0.0060
B
Vest4
0.16
MutPred
0.22
Gain of glycosylation at S419 (P = 0.1163);
MVP
0.56
MPC
0.85
ClinPred
0.30
T
GERP RS
4.9
Varity_R
0.076
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs754961645; hg19: chr15-76496303; API